MX2012010528A - Composicion farmaceutica con actividad antimicrobiana y antiinflamatoria para administracion parenteral y procedimiento de produccion de la misma. - Google Patents
Composicion farmaceutica con actividad antimicrobiana y antiinflamatoria para administracion parenteral y procedimiento de produccion de la misma.Info
- Publication number
- MX2012010528A MX2012010528A MX2012010528A MX2012010528A MX2012010528A MX 2012010528 A MX2012010528 A MX 2012010528A MX 2012010528 A MX2012010528 A MX 2012010528A MX 2012010528 A MX2012010528 A MX 2012010528A MX 2012010528 A MX2012010528 A MX 2012010528A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- preparing
- parenteral administration
- antimicrobial
- silicon dioxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a farmacología, medicina, veterinaria e industria farmacéutica. Se refiere en particular al procedimiento de producción de preparaciones antimicrobianas compuestas originales para administración parenteral, que presentan una eficacia terapéutica superior en el caso de enfermedades infecciosas e inflamatorias graves. Los agentes activos de las composiciones farmacéuticas propuestas son fosfomicina y dióxido de silicio nanoestructurado finamente disperso. Dicho procedimiento de producción de composición farmacéutica incluye mezclar fosfomicina con dióxido de silicio nanoestructurado finamente disperso. Se caracteriza principalmente porque dicha mezcla de sustancias con una razón en peso de desde 10:1 hasta 75:1, respectivamente, se expone a procesamiento mecánico mediante operaciones de abrasión por impacto hasta que aumenta la proporción en peso de la fracción de polvo fino (< 5 micrómetros) y pasa a ser no inferior al 25%. La mezcla obtenida se usa para la preparación de inyecciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201001507A EA021876B1 (ru) | 2010-09-20 | 2010-09-20 | Фармацевтическая композиция антимикробного и противовоспалительного действия для парентерального введения, способ ее получения |
PCT/RU2011/000321 WO2012039641A1 (ru) | 2010-09-20 | 2011-05-11 | Фармацевтическая композиция антимикробного и противовоспалительного действия для парентерального введения, способ её получения |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012010528A true MX2012010528A (es) | 2012-12-17 |
Family
ID=45874027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012010528A MX2012010528A (es) | 2010-09-20 | 2011-05-11 | Composicion farmaceutica con actividad antimicrobiana y antiinflamatoria para administracion parenteral y procedimiento de produccion de la misma. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20130164336A1 (es) |
EP (1) | EP2476419A4 (es) |
JP (1) | JP2013537226A (es) |
CN (1) | CN102740858A (es) |
AU (1) | AU2011304261C1 (es) |
BR (1) | BR112012023963A2 (es) |
CA (1) | CA2780785A1 (es) |
EA (1) | EA021876B1 (es) |
MX (1) | MX2012010528A (es) |
UA (1) | UA103116C2 (es) |
WO (1) | WO2012039641A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2476206C1 (ru) | 2011-11-22 | 2013-02-27 | Виктор Львович Лимонов | Фармацевтическая композиция для приготовления инфузионных растворов антимикробных препаратов, способ ее получения (варианты) |
EP3219305A1 (de) | 2016-03-16 | 2017-09-20 | Apostolos Georgopoulos | Fosfomycin-formulierung zur parenteralen verabreichung |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2179944A (en) * | 1985-09-03 | 1987-03-18 | Espan Penicilin & Antibioticos | Mixtures of mono- and disodium salts of fosfomycin |
ITMI20021725A1 (it) * | 2002-08-01 | 2002-10-31 | Zambon Spa | Composizioni farmaceutiche ad attivita' antibiotica. |
ES2244333B1 (es) * | 2004-05-18 | 2006-08-01 | Simbec Iberica, Sl | Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos. |
-
2010
- 2010-09-20 EA EA201001507A patent/EA021876B1/ru not_active IP Right Cessation
-
2011
- 2011-05-11 US US13/389,533 patent/US20130164336A1/en not_active Abandoned
- 2011-05-11 JP JP2013529098A patent/JP2013537226A/ja not_active Withdrawn
- 2011-05-11 WO PCT/RU2011/000321 patent/WO2012039641A1/ru active Application Filing
- 2011-05-11 CN CN2011800041985A patent/CN102740858A/zh active Pending
- 2011-05-11 AU AU2011304261A patent/AU2011304261C1/en not_active Ceased
- 2011-05-11 BR BR112012023963A patent/BR112012023963A2/pt not_active IP Right Cessation
- 2011-05-11 UA UAA201203807A patent/UA103116C2/ru unknown
- 2011-05-11 MX MX2012010528A patent/MX2012010528A/es not_active Application Discontinuation
- 2011-05-11 EP EP11827038.8A patent/EP2476419A4/en not_active Withdrawn
- 2011-05-11 CA CA2780785A patent/CA2780785A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2476419A4 (en) | 2013-07-17 |
AU2011304261B2 (en) | 2012-06-28 |
AU2011304261C1 (en) | 2012-11-29 |
BR112012023963A2 (pt) | 2016-08-02 |
CN102740858A (zh) | 2012-10-17 |
JP2013537226A (ja) | 2013-09-30 |
EA021876B1 (ru) | 2015-09-30 |
AU2011304261B8 (en) | 2012-07-05 |
AU2011304261A8 (en) | 2012-07-05 |
CA2780785A1 (en) | 2012-03-29 |
AU2011304261A1 (en) | 2012-04-19 |
EA201001507A1 (ru) | 2012-02-28 |
UA103116C2 (ru) | 2013-09-10 |
WO2012039641A1 (ru) | 2012-03-29 |
EP2476419A1 (en) | 2012-07-18 |
US20130164336A1 (en) | 2013-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2012007410A (es) | Compuestos antivirales novedosos. | |
NZ602557A (en) | Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | |
MX2012012225A (es) | Profármacos de agentes tearapéuticos de liberación de óxido nítrico. | |
JP2015517488A5 (es) | ||
GB0814302D0 (en) | Compounds and methods | |
CA2716874A1 (en) | A pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases | |
MX2011007817A (es) | Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion. | |
MX344787B (es) | Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara. | |
IL276194B2 (en) | Pharmaceutical compounds or preparations containing them for use in the treatment of pain | |
MX2017013636A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas. | |
MX2010004556A (es) | Formulacion farmaceutica de acido clavulanico. | |
WO2012039642A8 (ru) | Фармацевтическая композиция антимикробного и ранозаживляющего действия для наружного применения, способ её получения | |
WO2012042197A3 (en) | Low dose pharmaceutical composition comprising zanamivir | |
MX2012010528A (es) | Composicion farmaceutica con actividad antimicrobiana y antiinflamatoria para administracion parenteral y procedimiento de produccion de la misma. | |
BR112012022209A2 (pt) | composições farmacêuticas compreendendo monoterpenos | |
EA201100735A1 (ru) | Фармацевтическая композиция антибактериального действия для парентерального применения, способ ее получения | |
AR086491A1 (es) | Composicion farmaceutica que comprende fexofenadina | |
MX2017013633A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas. | |
WO2012028965A3 (ru) | Композиция семакса и холина альфосцера, обладающая противогипоксической, нейропротекторной и антиамнестической активностью и повышающая физическую работоспособность | |
CN102326535A (zh) | 农药助剂及其制作方法 | |
UA103118C2 (ru) | Фармацевтическая композиция антимикробного действия для парентерального введения и способ ее получения | |
MX2022015232A (es) | Composicion farmaceutica acuosa de levilimab y su uso. | |
MX2017013643A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz. | |
EA201100733A1 (ru) | Фармацевтическая композиция для лечения туберкулеза и других инфекций, способ ее получения | |
WO2012036585A8 (ru) | Фармацевтическая композиция антимикробного действия для парентерального введения и способ её получения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |